Literature DB >> 30881613

Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors.

A Keeley1, P Ábrányi-Balogh1, G M Keserű1.   

Abstract

A fragment library of electrophilic small heterocycles was characterized through cysteine-reactivity and aqueous stability tests that suggested their potential as covalent warheads. The analysis of theoretical and experimental descriptors revealed correlations between the electronic properties of the heterocyclic cores and their reactivity against GSH that are helpful in identifying suitable fragments for cysteines with specific nucleophilicity. The most important advantage of these fragments is that they show only minimal structural differences from non-electrophilic counterparts. Therefore, they could be used effectively in the design of targeted covalent inhibitors with minimal influence on key non-covalent interactions.

Entities:  

Year:  2018        PMID: 30881613      PMCID: PMC6390469          DOI: 10.1039/c8md00327k

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


Introduction

Heterocyclic rings and ring systems are among the key building blocks of drugs and drug-like compounds. It has been shown that 80 of the top 100 most frequently used ring systems among small-molecule drugs are nitrogen, oxygen and/or sulphur heterocycles.1 The abundance of heterocycles can be traced back to HTS2 and fragment-screening decks3 that contribute significantly to lead discovery efforts. Most of the heterocyclic scaffolds form non-covalent interactions with the target; however, the emergence of targeted covalent inhibitors (TCIs) highlights their use as potential electrophilic warheads. The actual design paradigm of covalent inhibitors primarily involves targeting cysteines by attaching electrophilic functional groups to known non-covalent scaffolds.4 These reactive warheads are typically acrylamides, but haloketones, haloacetyl amides, isothiocyanates, and maleimides are also prevalent.5,6 As a consequence of this design strategy, the non-covalent ligand is equipped with at least three (isothiocyanate: –NCS), but most often more than four, extra atoms (e.g., the most common acrylamide: –CHCH–C(O)NR2). This extension affects the molecular recognition and the binding mode of the non-covalent scaffold and requires the iterative optimization of electrophile geometry and linker length to engage the targeted cysteine successfully. Starting from relevant heterocyclic cores, here we design and characterize an electrophilic fragment library having minimal influence on the potential non-covalent interactions. Based on the well-known electron-withdrawing character of heterocycles,7 our intention was to turn them into fragment electrophiles with the introduction of the smallest available substituents (max. 1–2 atoms). We hypothesized that electron-withdrawing heterocycles activate the small electrophilic substituents and yield warheads suitable for cysteine-targeting covalent inhibitors. Testing this idea, we collected a wide range of five- and six-membered nitrogen-containing heterocycles combined with a selection of small electrophilic warheads. Library members were then subjected to detailed characterization that included the assessment of their cysteine reactivity, specificity and aqueous stability. Screening electrophilic fragments is now an emerging strategy in both ligand discovery8 and target identification,9 and they can serve as starting points in TCI programs.10 We believe that the library described here might facilitate the development of TCIs by replacing their heterocyclic scaffold with one of our electrophilic heterocycles. This approach would allow the precise positioning of the reactive group toward a catalytic/non-catalytic protein nucleophile in the proximity of the binding site11 while maintaining the key non-covalent interactions.

Results and discussion

The heterocyclic fragment library was composed of five- and six-membered heterocycles, particularly pyridine, pyrimidine, pyrazine, imidazole, pyrazole, oxazole, isoxazole and thiazole, while the corresponding six warheads were the halogens Cl, Br, and I reacting through aromatic nucleophilic substitution (SNAr), and the two-atom nitrile, vinyl and ethynyl groups reacting through nucleophilic addition (AdN) to cysteines. We planned to investigate the influence of the different heterocycles and the effect of warhead positions by evaluating the fragment's reactivity experimentally. Moreover, we aimed to identify theoretical descriptors supporting the design of new fragments with tailored reactivity. Furthermore, we intended to analyse the reactivity differences between the halogen atoms for the SNAr and that of the nitrile, vinyl and ethynyl groups for the AdN reactions. We have compiled the library from 84 electrophilic heterocycles, out of which 27 were synthesized in our laboratory. The pyridine, pyrimidine, imidazole and pyrazole rings were substituted at three different positions; the oxazole and thiazole rings at two positions; and finally the pyrazine and isoxazole at one available position. Notably, in some cases, the 1-substituted compound was not available; therefore, 2-chlorobenzoxazole, 2-bromo- and 2-vinyl-5-phenyloxazole, 3,5-dimethylisoxazoles and 2-chlorobenzothiazole were considered (see Tables 1 and S1† for the chemical structures of the library).
Table 1

GSH reactivity of heterocyclic electrophiles measured at concentrations of 250 μM. Library members having t1/2(GSH) > 72 h were considered inactive and are shown in Table S1

IDStructure k GSH t 1/2(GSH) [h]IDStructure k GSH t 1/2(GSH) [h]
A1 0.010069.4 K6 0.14124.9
A2 0.010069.2 L6 0.40441.7
A5 0.68871.0 N1 0.15334.5
B4 0.017641.0 N3 6.05730.1
C3 0.010069.0 N4 1.46150.5
C4 0.88370.8 N5 0.015345.2
C5 2.41500.3 N6 0.012754.6
C6 0.29002.4 O4 0.6931.0
D4 0.31382.2 P6 0.12845.4
D6 0.015146.8 Q2 0.01163.0
E4 0.014747.1 Q5 0.015644.5
G4 0.031422.5 Q6 0.013053.1
G5 0.041416.9 R3 0.78720.9
H3 0.1166.0 R4 0.08688.0
H4 0.013252.3 R5 0.25832.7
I6 0.014448.0
First, the stability and reactivity of the library members were investigated in a GSH-based assay (Fig. 1) using HPLC-MS (Fig. 1 IIa) or NMR-based kinetic methods (Fig. 1 IIb).12 We measured the decreasing amount of the electrophilic fragment up to 72 h in two parallel measurements. The aqueous stability of the compounds was characterized by the fragment half-life calculated from the equation t1/2(deg) = ln 2/kdeg, where the degradation rate constant for auto-degradation (kdeg) was calculated by linear regression of the measured datapoints in the absence of GSH. Thiol reactivity was assessed by measuring fragment depletion with a large excess of GSH12 that provided the rate constant kdeg+GSH as the sum of the thiol-reactivity and the degradation. The GSH reactivity of the electrophile was then calculated from these two rate constants as kGSH = kdeg+GSH – kdeg. The GSH half-life (t1/2(GSH)) was determined from the kGSH thiol-reactivity rate constant.
Fig. 1

Representation of the (A) HPLC- (IIa) and NMR-based (IIb) thiol-reactivity studies with the (B) corresponding calculations.

Stability data confirmed that all of the compounds showed the appropriate stability (>1 h) required for biological testing (Table S1†).3 Notably, the less stable species were found in isoxazoles (t1/2(deg) < 17 h), while 2-chlorobenzoxazole and 2-chlorobenzothiazole also had t1/2(deg) < 24 h. The results of the GSH reactivity assay revealed that heterocyclic electrophiles cover a wide range of thiol reactivity (Tables 1 and S1†). The library contained fragments reacting under 1 h (C4 (0.8 h), C5 (0.3 h), N3 (0.1 h), N4 (0.5 h), Table 1) to compounds considered practically non-reactive, with t1/2(GSH) > 72 h (shown in Table S1†). Since the library is intended for use in labelling cysteine nucleophiles, we considered two major subsets of the compounds. The first subset involves compounds with nitrile, vinyl and ethynyl substituents that react through nucleophilic addition (AdN). The second set consists of halogenated derivatives that label cysteine in nucleophilic substitution reactions (SNAr). Comparing the six-membered fragments, we found that halogenated compounds showed weak reactivity (for A1, A2, A3, B2, C1, C2, C3, D2, E1, F1, F2, G1, t1/2(GSH) > 69 h, and B1, B3, D1, D3, F3, G2, G3 were essentially non-reactive). In contrast, the cyano-, vinyl- and ethynylpyridines at position 4 (C4 (0.8 h), C5 (0.3 h), C6 (2.4 h), respectively) reacted quickly (Table 1). In the pyrimidine subset equipped with CN or ethynyl groups, position 2 between the two nitrogens gave the shortest half-lives (D4 (2.2 h), D6 (46.8 h) (Table 1)). Among vinylated six-membered heterocycles, pyridines were the most potent electrophiles (A5 (1.0 h), C5 (0.3 h), Table 1). Taking a closer look at the cyano derivatives, position 4 of the pyridine (C4, 0.8 h) and position 2 of the pyrimidine (D4, 2.2 h) and the pyrazine (G4, 22.5 h) rings were most reactive (Table 1). Focusing on the five-membered heterocycles, among the imidazole derivatives, only 2-iodoimidazole (H3, 6.0 h) showed considerable reactivity, and among pyrazoles, only 3-ethynyl- (K6, 4.9 h) and 4-ethynylpyrazole (L6, 1.7 h) were reactive (Table 1). In the case of the oxazole core, the 2-iodo- (N3, 0.1 h), 2-cyano- (N4, 0.5 h) and 4-cyanooxazole (O4, 1.0) showed remarkable reactivity (Table 1). From the 3,5-dimethylisoxazoles, only the 4-ethynyl derivative (P6, 5.4 h) was reactive (Table 1). Thiazoles were, in particular, the most reactive heterocycles in the five-membered group. Their nitrile and vinyl derivatives were most active when located between the heteroatoms at position 2 (R4 (8.0 h), R5 (2.7 h), respectively, Table 1). In contrast, bromine and ethynyl derivatives (Q2 (63.0 h) and Q6 (53.1 h), respectively) performed best at position 5 (Table 1). Next, we analysed the reactivity trends quantitatively using computed descriptors and experimental (log)t1/2(GSH) values (see Table S2†). The Gaussian09 program package with the B3LYP/6-311++(2d,2p) method and basis set was used to calculate the HOMO (εH) and LUMO energies (εL) and electron distribution on the reacting carbon atom ( and ) at the neutral and also at the –1 charged state, based on the atomic charge distributions in terms of natural population analysis (NPA). From these values, we have calculated the chemical hardness (η = εL – εH), electronic chemical potential (μ = (εL + εH)/2), Parr-index (global electrophilicity, ω = μ2/2η), Fukui-function (frontier function, f+(r[combining right harpoon above]) = ) and local electrophilicity index (ω(r[combining right harpoon above]) = ω·f+(r[combining right harpoon above])).13 Furthermore, we have computed the transition state enthalpies and Gibbs free energies for the reaction of the chloro- and vinyl-derivatives (modelling SNAr and AdN reactions, respectively) with the MeS– anion as a cysteine surrogate. Inductive sigma constants for the heterocyclic rings were calculated by ACD/Percepta (see Table S2†). Calculation of the Pearson and Spearman correlation coefficients between each of the descriptors and experimental GSH half-lives revealed no significant correlation when considering the whole library. Taking into account, however, the reaction types between the electrophilic fragments and the targeted nucleophile, we identified some interesting trends. In the case of halogen derivatives reacting in nucleophilic substitutions, we found that the GSH half-life decreases with increasing electronic chemical potential for the halogen set (Fig. 2). Changes in the electronic chemical potential are opposite that of the electron affinity14 and related to the corresponding HOMO energies. This explains why a higher potential is associated with more reactive species with higher εH and with low (log)t1/2(GSH). Notably, the more electrophilic fragments with higher HOMO energies are more reactive towards the nucleophilic cysteine.
Fig. 2

Logarithm of the GSH half-life vs. electronic potential for the halogen set. Standard errors are also shown.

In the case of ethynyl-substituted fragments reacting in nucleophilic additions, we found that the GSH half-life decreases with increasing atomic charge, which indicates decreasing electron density () for the ethynyl set (Fig. 3). This trend showed that the lower electron density is advantageous for thiol reactivity, since readily ionisable electrophiles and the resulting electron-poor carbon atoms can be considered more reactive towards the thiol nucleophile. This analysis revealed that the prediction of the GSH reactivity requires different descriptors depending on the reaction mechanism. In the case of AdN reactions, the warhead itself does not influence the reactivity, but the local electron distribution on the reacting carbon caused by the electron-withdrawing effect of the aromatic substituent is determining. Moreover, the negative charge is localised on the warhead in the transition state (TS), and the intermediate in AdN reactions implicates the use of a local electronic descriptor. Taking a closer look at SNAr reactions, the aromatic core and the halogen atom should be treated together due to the characteristic leaving group effect. Furthermore, the negative charge is dissipated in the TS. These two factors indicate that a global descriptor is more accurate for the prediction of the reactivity.
Fig. 3

Logarithm of the GSH half-life vs. atomic charge distribution for the ethynyl set. Standard errors are also shown.

Conclusions

Recent strategies of covalent drug design have been focusing on the optimization of the non-covalent scaffold followed by the attachment of extended warheads, commonly Michael acceptors. In this work, we have developed a heterocyclic electrophilic fragment library from the combination of eight five- or six-membered heterocycles and six small one- or two-atom warheads acting through aromatic nucleophilic substitution or nucleophilic addition. The systematic characterization of this library resulted in compounds with appropriate stability and a wide range of thiol reactivity (Fig. 4) that allow the selection of the most appropriate heterocyclic warhead depending on the nucleophilicity of the targeted cysteine. These heterocyclic electrophiles could be used to replace aromatic moieties in known non-covalent ligands and could present a useful alternative design strategy aiming at targeted covalent inhibitors. The characterized library is available for screening against relevant targets upon request from the authors.
Fig. 4

Measured GSH reactivity of diverse heterocycle moieties expressed in t1/2 (h). A high value indicates poor electrophilicity, whereas small values are attributed to more reactive electrophiles. Not represented are compounds whose t1/2 (h) is > 72 h.

Conflicts of interest

The authors declare no competing financial interests. Click here for additional data file.
  13 in total

1.  Revisiting the definition of the electronic chemical potential, chemical hardness, and softness at finite temperatures.

Authors:  Marco Franco-Pérez; José L Gázquez; Paul W Ayers; Alberto Vela
Journal:  J Chem Phys       Date:  2015-10-21       Impact factor: 3.488

2.  Covalent Tethering of Fragments For Covalent Probe Discovery.

Authors:  Stefan G Kathman; Alexander V Statsyuk
Journal:  Medchemcomm       Date:  2016-01-28       Impact factor: 3.597

Review 3.  The influence of lead discovery strategies on the properties of drug candidates.

Authors:  György M Keserü; Gergely M Makara
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 4.  Rings in drugs.

Authors:  Richard D Taylor; Malcolm MacCoss; Alastair D G Lawson
Journal:  J Med Chem       Date:  2014-02-17       Impact factor: 7.446

5.  Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.

Authors:  György M Keserű; Daniel A Erlanson; György G Ferenczy; Michael M Hann; Christopher W Murray; Stephen D Pickett
Journal:  J Med Chem       Date:  2016-05-16       Impact factor: 7.446

Review 6.  Structure-based design of targeted covalent inhibitors.

Authors:  Richard Lonsdale; Richard A Ward
Journal:  Chem Soc Rev       Date:  2018-06-05       Impact factor: 54.564

Review 7.  Targeted Covalent Inhibitors for Drug Design.

Authors:  Thomas A Baillie
Journal:  Angew Chem Int Ed Engl       Date:  2016-08-19       Impact factor: 15.336

8.  Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.

Authors:  Mark E Flanagan; Joseph A Abramite; Dennis P Anderson; Ann Aulabaugh; Upendra P Dahal; Adam M Gilbert; Chao Li; Justin Montgomery; Stacey R Oppenheimer; Tim Ryder; Brandon P Schuff; Daniel P Uccello; Gregory S Walker; Yan Wu; Matthew F Brown; Jinshan M Chen; Matthew M Hayward; Mark C Noe; R Scott Obach; Laurence Philippe; Veerabahu Shanmugasundaram; Michael J Shapiro; Jeremy Starr; Justin Stroh; Ye Che
Journal:  J Med Chem       Date:  2014-11-26       Impact factor: 7.446

9.  Ligand and Target Discovery by Fragment-Based Screening in Human Cells.

Authors:  Christopher G Parker; Andrea Galmozzi; Yujia Wang; Bruno E Correia; Kenji Sasaki; Christopher M Joslyn; Arthur S Kim; Cullen L Cavallaro; R Michael Lawrence; Stephen R Johnson; Iñigo Narvaiza; Enrique Saez; Benjamin F Cravatt
Journal:  Cell       Date:  2017-01-19       Impact factor: 41.582

Review 10.  Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity.

Authors:  Luis R Domingo; Mar Ríos-Gutiérrez; Patricia Pérez
Journal:  Molecules       Date:  2016-06-09       Impact factor: 4.411

View more
  9 in total

1.  Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination.

Authors:  Thanigaimalai Pillaiyar; Philipp Flury; Nadine Krüger; Haixia Su; Laura Schäkel; Elany Barbosa Da Silva; Olga Eppler; Thales Kronenberger; Tianqing Nie; Stephanie Luedtke; Cheila Rocha; Katharina Sylvester; Marvin R I Petry; James H McKerrow; Antti Poso; Stefan Pöhlmann; Michael Gütschow; Anthony J O'Donoghue; Yechun Xu; Christa E Müller; Stefan A Laufer
Journal:  J Med Chem       Date:  2022-06-16       Impact factor: 8.039

2.  Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening.

Authors:  Efrat Resnick; Anthony Bradley; Jinrui Gan; Alice Douangamath; Tobias Krojer; Ritika Sethi; Paul P Geurink; Anthony Aimon; Gabriel Amitai; Dom Bellini; James Bennett; Michael Fairhead; Oleg Fedorov; Ronen Gabizon; Jin Gan; Jingxu Guo; Alexander Plotnikov; Nava Reznik; Gian Filippo Ruda; Laura Díaz-Sáez; Verena M Straub; Tamas Szommer; Srikannathasan Velupillai; Daniel Zaidman; Yanling Zhang; Alun R Coker; Christopher G Dowson; Haim M Barr; Chu Wang; Kilian V M Huber; Paul E Brennan; Huib Ovaa; Frank von Delft; Nir London
Journal:  J Am Chem Soc       Date:  2019-05-22       Impact factor: 15.419

3.  Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities.

Authors:  Robert J Mayer; Armin R Ofial
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-31       Impact factor: 15.336

4.  Multicomponent reaction-derived covalent inhibitor space.

Authors:  Fandi Sutanto; Shabnam Shaabani; Constantinos G Neochoritis; Tryfon Zarganes-Tzitzikas; Pravin Patil; Ehsan Ghonchepour; Alexander Dömling
Journal:  Sci Adv       Date:  2021-02-03       Impact factor: 14.136

5.  Quadruple Target Evaluation of Diversity-Optimized Halogen-Enriched Fragments (HEFLibs) Reveals Substantial Ligand Efficiency for AP2-Associated Protein Kinase 1 (AAK1).

Authors:  Marcel Dammann; Markus Kramer; Markus O Zimmermann; Frank M Boeckler
Journal:  Front Chem       Date:  2022-02-02       Impact factor: 5.221

Review 6.  Advances in covalent drug discovery.

Authors:  Lydia Boike; Nathaniel J Henning; Daniel K Nomura
Journal:  Nat Rev Drug Discov       Date:  2022-08-25       Impact factor: 112.288

7.  Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.

Authors:  Levente Kollár; Martina Gobec; Matic Proj; Lara Smrdel; Damijan Knez; Tímea Imre; Ágnes Gömöry; László Petri; Péter Ábrányi-Balogh; Dorottya Csányi; György G Ferenczy; Stanislav Gobec; Izidor Sosič; György M Keserű
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

8.  4-Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2.

Authors:  Zhangping Xiao; Deng Chen; Fabian Mulder; Shanshan Song; Petra E van der Wouden; Robbert H Cool; Barbro N Melgert; Gerrit J Poelarends; Frank J Dekker
Journal:  Chemistry       Date:  2021-11-22       Impact factor: 5.020

9.  Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.

Authors:  Alice Douangamath; Daren Fearon; Paul Gehrtz; Tobias Krojer; Petra Lukacik; C David Owen; Efrat Resnick; Claire Strain-Damerell; Anthony Aimon; Péter Ábrányi-Balogh; José Brandão-Neto; Anna Carbery; Gemma Davison; Alexandre Dias; Thomas D Downes; Louise Dunnett; Michael Fairhead; James D Firth; S Paul Jones; Aaron Keeley; György M Keserü; Hanna F Klein; Mathew P Martin; Martin E M Noble; Peter O'Brien; Ailsa Powell; Rambabu N Reddi; Rachael Skyner; Matthew Snee; Michael J Waring; Conor Wild; Nir London; Frank von Delft; Martin A Walsh
Journal:  Nat Commun       Date:  2020-10-07       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.